ENDPOINTS NEWS13m
Af­ter lack­lus­ter 2024, bio­phar­ma in­dus­try prays stalled M&A will fi­nal­ly move in­to gear
Biopharma leaders head to San Francisco's JP Morgan Healthcare Conference amid hopes for M&A deals after slow 2024, which saw ...
ENDPOINTS NEWS59m
Sam­sung Bio ex­tends ADC part­ner­ship; Vee­da re­brands as CD­MO
Sutro scale-up, Pharma mergers, FDA warnings to Indian firms, new Egypt facility, and UPS acquires Frigo-Trans ...
ENDPOINTS NEWS1h
Num­ab ex­tends its Se­ries C; AnaC­ar­dio rais­es $19M for its heart fail­ure drug
RheumaGen raises $15M Series A for HLA gene editing in autoimmune diseases, while RyboDyn gets $4M pre-seed to study non-coding DNA for cancer immunotherapies ...